Pelvic malignant mesenchymoma. A case report
DOI:
https://doi.org/10.5281/zenodo.8128693Keywords:
malignant mesenchymoma, histology, treatmentAbstract
It was reported a case of a 73 years old patient with a history of an unknown outcomes surgical procedure 5 years ago at the Hospital Clínico Quirúrgico Docente “Amalia Simoni” in Camaguey, Cuba. He presented pain and functional limitation of the right lower limb, which led to the resection of a tumor in the ipsilateral femur; five years later the tumour present signs of recurrence, this time with invasion of the bony pelvis and rectum and resulting in urinary disorders and constipation. Pelvis bone radiology, computed tomography scan and magnetic resonance imaging of the pelvis showed a mixed tumor with lytic lesions that invaded and displaced the organs in the pelvic cavity. The patient underwent excision of the tumor, which was 173×156 mm, weighing approximately 1.380 g. Histopathological analysis of the surgical resection specimen revealed a pelvic malignant mesenchymoma.
Downloads
References
Stout AP. Mesenchymoma: the mixed mesenchymal derivates. Ann Surg. 1948; 127:278-90.
Occhionorelli S, Pigato I, Malvicini E, Pascale G, Stano R, Rinaldi R, Vasquez G. Solitary fibrous tumour of gluteus: a case report an uncommon localization of a rare neoplasm. J Surg Case Rep [Internet] 2016 [citado 10 Jun 2023]; 2016(6):rjw111. DOI: https://doi.org/10.1093/jscr/rjw111
Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2020. CA Cancer J Clin [Internet]. 2020 [citado 10 Jun 2023]; 70(1):7-30. DOI: https://doi.org/10.3322/caac.21590
WHO Cancer Mortality Database. www.who.int. [citado 10 Ene 2023]. Disponible en: https://www.who.int/data/data-collection-tools/who-mortality-database
Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, et al. Cancer incidence in Five Continents. v. XI. Lyon: International Agency for Research on Cancer; 2017. [citado 19 Ene 2023]. Disponible en: https://ci5.iarc.fr/Default.aspx
Siegel GW, Biermann JS, Lucas D, Chugh R, Jacobson JA, Lucas D, et al. The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework. J Multidiscip Healthc [Internet]. 2015 [citado 10 Jun 2023]; 8:109-15. DOI: https://doi.org/10.2147/jmdh.s49805
Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Lopez-Pousa A, Grignani G, et al. sarcoma Full-dose neoadjuvant anthracycline + ifosfamide chemotherapy is associated with relapse free survival (RFS) and overall survival (OS) benefit in localized high-risk adult soft tissue sarcoma (STS) of the extremities and trunk wall: interim analysis of a prospective randomized trial. Ann Oncol. 2016;27(6):VI587. DOI: https://doi.org/10.1093/annonc/mdw435.52
American Cancer Society: Cancer Facts and Figures 2015. Atlanta; Ga: American Cancer Society, 2015. Disponible en: http://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pineros M, et al. Global Cancer Observatory: Cancer Today. gco.iarc.fr. Lyon, France: International Agency for Research on Cancer; 2018 [citado 24 Abr 2023]. Disponible en: https://gco.iarc.fr/today
Claudia S, Patel L, Malvezzi M, Wojtyla C, La Vecchia C, Negri E, et al. Persisting cancer mortality gap between western and eastern Europe. Eur J Cancer [Internet]. 2022 [citado 10 Jun 2023]; 165:1-12. DOI: https://doi.org/10.1016/j.ejca.2022.01.007
Mesquijo JJ, Santori F, Inmocenti S. Mesenquimoma fibrocartilaginoso de húmero proximal: reporte de un caso. Arch Argent Pediatr [Internet]. 2014 [citado 10 Jun 2023]; 112(5):301-5. DOI: http://dx.doi.org/10.5546/aap.2014.e222
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pedro León-Acosta, Pedro Rosales-Torres, Rafael Pila-Pérez
This work is licensed under a Creative Commons Attribution 4.0 International License.
